• Losartan: Redefining Translational Research in Tumor and Vas

  2026-07-29

  This thought-leadership article examines Losartan’s dual impact as a selective angiotensin II receptor antagonist in cardiovascular and oncology research. It synthesizes mechanistic insights with strategic guidance, highlighting recent breakthroughs in tumor microenvironment modulation and the evolving toolkit for translational scientists.

• Applied Workflows with (S)-1-(3-fluoro-4-(trifluoromethoxy)p

  2026-07-29

  Leverage (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) to enable high-precision enzyme inhibition and signaling pathway modulation, especially in osteoporosis and redox biology research. This guide details robust experimental setups, actionable troubleshooting, and best-practice parameters for maximizing reproducibility and sensitivity with this fluorinated phenyl urea compound.

• EdU Imaging Kits (HF488): Precision Proliferation Insights i

  2026-07-28

  Explore how EdU Imaging Kits (HF488) revolutionize 5-ethynyl-2'-deoxyuridine-based cell proliferation assays, offering unmatched sensitivity and mechanistic clarity for advanced cancer research. Discover unique insights that go beyond workflow and troubleshooting.

• Erastin and the Ferroptosis Frontier: Precision Tools for Tr

  2026-07-28

  This thought-leadership article explores the mechanistic underpinnings and translational strategy for deploying Erastin—a benchmark ferroptosis inducer—in cancer biology research. Integrating insights from recent nanomedicine studies and established workflows, it provides actionable guidance for researchers navigating the evolving landscape of oxidative cell death and tumor vulnerability. The discussion connects Erastin’s unique mechanistic selectivity to new opportunities in immunogenic cell death, underlining APExBIO’s role in delivering rigorously validated reagents for advanced cancer research.

• RIG-I Drives Renal Fibrosis via c-Myc Activation in UUO Mice

  2026-07-27

  This study demonstrates that RIG-I significantly exacerbates renal interstitial fibrosis through c-Myc-mediated fibroblast activation and TGF-β/Smad signaling in mouse models of kidney injury. The findings clarify a new mechanistic axis in chronic kidney disease progression, offering important targets for future therapeutic intervention and mechanistic research.

• Baicalin Methyl Ester: Mechanisms and Benchmarks in Gut Barr

  2026-07-27

  Baicalin methyl ester, an esterified derivative of baicalin, modulates the P65/TNF-α/MLCK/ZO-1 signaling pathway and protects against LPS-induced intestinal barrier damage. Its efficacy is supported by both in vitro and in vivo studies with defined concentration and dose ranges. This compound is a validated anti-inflammatory agent in intestinal epithelial cell research.

• RSV NS3 Orchestrates Host Kinase Signaling for Pathogenicity

  2026-07-26

  Zhuang et al. (2025) uncover how Rice stripe virus (RSV) NS3 protein finely regulates its own pathogenicity and transmission by manipulating host kinase signaling pathways through dynamic phosphorylation and protein interactions. These discoveries illuminate the mechanistic basis for virus-host-vector co-survival and highlight new avenues for targeted research in plant pathology and host-pathogen interactions.

• Y-27632 Dihydrochloride: ROCK Inhibitor for Advanced Cell Wo

  2026-07-25

  Y-27632 dihydrochloride accelerates stem cell viability, organoid formation, and invasion modeling by offering potent, selective ROCK inhibition with outstanding reproducibility. Discover protocol enhancements, troubleshooting, and innovations inspired by recent gut-brain axis research—all leveraging APExBIO’s trusted product portfolio.

• Nelfinavir Mesylate: HIV-1 Protease Inhibitor for Advanced R

  2026-07-24

  Nelfinavir Mesylate stands out as a dual-purpose, high-potency HIV-1 protease inhibitor with unmatched utility in both antiviral and cell death pathway research. Its robust quantitative benchmarks, ability to sensitize cells to ferroptosis, and reproducible performance make it indispensable for innovators seeking translational leverage.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract

  2026-07-24

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is designed to prevent protein degradation during extraction workflows while maintaining compatibility with divalent cation-dependent assays. It should be used when broad-spectrum protease inhibition is required, but not when metalloprotease inhibition via EDTA is necessary. Researchers benefit from its concentrated, EDTA-free formulation for applications such as Western blotting, co-immunoprecipitation, and phosphorylation analysis.

• RIG-I Drives Renal Fibrosis via c-Myc and Fibroblast Activat

  2026-07-23

  This study reveals that RIG-I, an intracellular RNA sensor, exacerbates renal interstitial fibrosis by promoting inflammatory cytokine production in tubular epithelial cells and activating c-Myc-mediated TGF-β/Smad signaling in fibroblasts. The findings highlight novel molecular links in chronic kidney disease progression and identify RIG-I as a potential target for antifibrotic intervention.

• A High-Throughput Surrogate Model for BBB Permeability Predi

  2026-07-23

  This study introduces a robust in vitro blood-brain barrier (BBB) model based on LLC-PK1-MOCK/MDR1 cells, enabling high-throughput prediction of brain penetration for CNS drugs. By integrating lysosomal trapping correction, the model closely mirrors in vivo drug distribution, streamlining early-stage CNS drug screening and reducing dependency on animal studies.

• Molidustat (BAY85-3934): Optimizing HIF Stabilization Workfl

  2026-07-22

  Molidustat (BAY85-3934) unlocks robust, physiologically relevant HIF stabilization for renal anemia and hypoxia research. This article delivers actionable protocol guidance, experimental troubleshooting, and cross-study insights to maximize translational impact using APExBIO’s validated compound.

• Fluorouracil (Adrucil) in Solid Tumor Evolution: Precision T

  2026-07-22

  Explore how Fluorouracil (5-Fluorouracil) enables advanced modeling of therapeutic heterogeneity in colon and breast cancer research. Uncover novel assay strategies grounded in recent genomic findings and learn how APExBIO's formulation advances reproducibility.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox P

  2026-07-21

  GKT137831 empowers researchers to precisely inhibit Nox1 and Nox4, dissecting reactive oxygen species dynamics in advanced models of vascular remodeling and fibrosis. Its nanomolar potency, workflow flexibility, and troubleshooting versatility make it a gold standard for translational redox research.

411 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page